92 related articles for article (PubMed ID: 9484779)
1. Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein.
Bessard AC; Garay E; Lacronique V; Legros Y; Demarquay C; Houque A; Portefaix JM; Granier C; Soussi T
Oncogene; 1998 Feb; 16(7):883-90. PubMed ID: 9484779
[TBL] [Abstract][Full Text] [Related]
2. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
Hansen S; Lane DP; Midgley CA
J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
[TBL] [Abstract][Full Text] [Related]
3. Xenopus laevis p53 protein: sequence-specific DNA binding, transcriptional regulation and oligomerization are evolutionarily conserved.
Wang Y; Farmer G; Soussi T; Prives C
Oncogene; 1995 Feb; 10(4):779-84. PubMed ID: 7862457
[TBL] [Abstract][Full Text] [Related]
4. Influence of the N-terminal region on the oligomerisation between human and Xenopus laevis p53.
Chène P
J Mol Biol; 1999 May; 288(5):883-90. PubMed ID: 10329186
[TBL] [Abstract][Full Text] [Related]
5. The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA element.
Zhang W; Guo XY; Deisseroth AB
Oncogene; 1994 Sep; 9(9):2513-21. PubMed ID: 8058314
[TBL] [Abstract][Full Text] [Related]
6. The UV responsive elements in the human mimecan promoter: a functional characterization.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
[TBL] [Abstract][Full Text] [Related]
7. Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein.
Legros Y; Lafon C; Soussi T
Oncogene; 1994 Jul; 9(7):2071-6. PubMed ID: 8208553
[TBL] [Abstract][Full Text] [Related]
8. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
[TBL] [Abstract][Full Text] [Related]
9. Epitope analysis of the human p53 tumour suppressor protein.
Dolezalová H; Vojtĕsek B; Kovarík J
Folia Biol (Praha); 1997; 43(1):49-51. PubMed ID: 9158951
[TBL] [Abstract][Full Text] [Related]
10. Signaling to p53: breaking the posttranslational modification code.
Appella E; Anderson CW
Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
[TBL] [Abstract][Full Text] [Related]
11. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus.
Shaw P; Freeman J; Bovey R; Iggo R
Oncogene; 1996 Feb; 12(4):921-30. PubMed ID: 8632915
[TBL] [Abstract][Full Text] [Related]
12. Acetylation and phosphorylation of the carboxy-terminal domain of p53: regulative significance.
Chiarugi V; Cinelli M; Magnelli L
Oncol Res; 1998; 10(2):55-7. PubMed ID: 9666512
[TBL] [Abstract][Full Text] [Related]
13. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
[TBL] [Abstract][Full Text] [Related]
14. Xenopus p53 is biochemically similar to the human tumour suppressor protein p53 and is induced upon DNA damage in somatic cells.
Cox LS; Midgley CA; Lane DP
Oncogene; 1994 Oct; 9(10):2951-9. PubMed ID: 8084598
[TBL] [Abstract][Full Text] [Related]
15. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
Di Como CJ; Prives C
Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
[TBL] [Abstract][Full Text] [Related]
16. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of DNA binding and in vitro transcriptional activities dependent on the C terminus of P53 proteins.
Kaku S; Albor A; Kulesz-Martin M
Biochem Biophys Res Commun; 2001 Jan; 280(1):204-11. PubMed ID: 11162500
[TBL] [Abstract][Full Text] [Related]
18. The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.
Wolkowicz R; Elkind NB; Ronen D; Rotter V
Oncogene; 1995 Mar; 10(6):1167-74. PubMed ID: 7535417
[TBL] [Abstract][Full Text] [Related]
19. Activation of p53 DNA binding activity by point mutation.
Marston NJ; Ludwig RL; Vousden KH
Oncogene; 1998 Jun; 16(24):3123-31. PubMed ID: 9671391
[TBL] [Abstract][Full Text] [Related]
20. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential.
Mundt M; Hupp T; Fritsche M; Merkle C; Hansen S; Lane D; Groner B
Oncogene; 1997 Jul; 15(2):237-44. PubMed ID: 9244359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
